ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Combination of mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) in the treatment of knee osteoarthritis: a meta-analysis of randomised controlled trials

Zhao, Jinlong; Liang, Guihong; Han, Yanhong; Yang, Weiyi; Xu, Nanjun; Luo, Minghui; Pan, Jianke; Liu, Jun*; Zeng, Ling-Feng*广东省人民医院; 广州中医药大学; 5
BMJ Open2022-11DOI: 10.1136/bmjopen-2022-061008
4被引9阅读
引用收藏
分享

摘要

Objectives The purpose of this meta-analysis was to investigate the efficacy and safety of mesenchymal stem cells (MSCs) combined with platelet-rich plasma (PRP) in the treatment of knee osteoarthritis (KOA). @@@ Design Systematic review and meta-analysis. @@@ Participants Patients with KOA. @@@ Interventions Use of MSCs+PRP. @@@ Primary and secondary outcomes Visual Analogue Scale (VAS) score, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score, Knee Injury and Osteoarthritis Outcome Score (KOOS) and adverse reactions. @@@ Data sources PubMed, Cochrane Library, Embase and China National Knowledge Infrastructure were searched from inception to 15 July 2021. @@@ Measures The OR or weighted mean difference (WMD) of relevant outcome indicators was calculated. Study quality was evaluated using the risk-of-bias assessment tool version 2.0. Heterogeneity among studies was evaluated by calculating I-2. If I-2<50%, a fixed-effect model was applied; conversely, if I-2 <= 50%, a random-effect model was applied. @@@ Results Six controlled clinical trials with 493 cases were included. The meta-analysis results showed that in terms of the VAS score 3 months after treatment, MSCs+PRP had no significant effect on the reduction of the VAS score in patients with KOA compared with the control (p=0.09), hyaluronic acid (HA) (p=0.15) or PRP alone (p=0.07). MSCs+PRP was more effective in reducing the VAS score at 6 and 12 months after treatment than the control (WMD=-0.55, 95% CI -0.87 to -0.22, p<0.001), HA (WMD=-1.20, 95% CI -2.28 to -0.13, p=0.03) or PRP alone (WMD=-0.54, 95% CI -0.89 to -0.18, p=0.003). Regarding the decrease in the total WOMAC score at 3 and 6 months after treatment, MSCs+PRP showed better clinical efficacy than the control or HA alone (p<0.01). Compared with the control, MSCs+PRP exhibited no significant difference in reducing the total WOMAC score 12 months after treatment (p=0.39). There was no significant difference between MSCs+PRP and the control in terms of improvement of the KOOS 12 months after treatment (p=0.16). Compared with MSCs alone, MSCs+PRP exhibited no significant difference in the incidence of adverse reactions (p=0.22) 12 months after treatment. @@@ Conclusions Treatment with MSCs+PRP showed good clinical efficacy in improving pain and joint function in patients with KOA. Compared with MSCs alone, there was no significant difference in the incidence of adverse reactions with MSCs+PRP.

学科与关键词

关键词
KneeAdult surgeryHealth informatics
相关
加载中…
  • Intra-Articular Mesenchymal Stromal Cell Injections Are No Different From Placebo in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Dai, Wenli; Leng, Xi; Wang, Jian; Shi, Zhanjun; Cheng, Jin; Hu, Xiaoqing*; Ao, Yingfang*Arthroscopy - Journal of Arthroscopic and Related Surgery, 2021, 37(1): 340-358.被引 26
  • The application of platelet-rich plasma in the treatment of knee osteoarthritis: A literature review
    Li, Wei; Pan, Jianying; Lu, Zhihui; Zhu, Huangrong; Guo, Jinshan; Xie, Denghui*JOURNAL OF ORTHOPAEDIC SCIENCE, 2022, 27(2): 420-428.被引 3
  • The Effectiveness of Single Injection of Platelet-Rich Plasma for Knee Osteoarthritis Combined with Meniscus Injury: A Randomized Trial
    Jiao, Rui; Zhang, Ming-Sheng*; Li, Xin-Ping; Li, Shu-Qian; Huang, Wen-XiaJournal of Biomaterials and Tissue Engineering, 2022, 12(2): 287-292.
查看全部 →

发表信息

论文状态
公开发表
期刊
BMJ Open
发表日期
2022-11
卷期
第 12 卷, 第 11 期
页码
e061008
DOI
10.1136/bmjopen-2022-061008
语言
ENGLISH
期刊等级
4区
成果收录
SCIE

作者

  • Z

    Zhao, Jinlong (第一作者)

    2 · guangzhou univ chinese med · guangdong prov hosp · guangdong prov acad chinese med sci

  • L

    Liang, Guihong

    2 · guangzhou univ chinese med · guangdong prov hosp · guangdong prov acad chinese med sci

查看全部 9 位作者收起作者
  • H

    Han, Yanhong

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Y

    Yang, Weiyi

    2 · guangdong prov hosp · guangzhou univ chinese med

  • X

    Xu, Nanjun

    2 · guangzhou univ chinese med

  • L

    Luo, Minghui

    2 · guangdong prov hosp · guangzhou univ chinese med

  • P

    Pan, Jianke

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Liu, Jun (通讯)

    5 · guangzhou univ chinese med · guangdong prov acad chinese med sci

  • Z

    Zeng, Ling-Feng (通讯)

    2 · guangzhou univ chinese med · guangdong prov hosp · guangdong prov acad chinese med sci

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417